Drug · DIN 02467771
ATOMOXETINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 15, 2018; first marketed January 15, 2018.
- Drug Identification Number (DIN)
- 02467771
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Atomoxetine N06BA09
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) | 40 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 24, 2017: NOC 19721Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named ATOMOXETINE
- DIN 02445883 · Marketed
- DIN 02445905 · Marketed
- DIN 02445913 · Marketed
- DIN 02445948 · Marketed
- DIN 02445956 · Marketed
- DIN 02467747 · Marketed
- DIN 02467755 · Marketed
- DIN 02467763 · Marketed
- DIN 02467798 · Marketed
- DIN 02467801 · Marketed
- DIN 02467828 · Marketed